Vigmed Holding AB has published the Annual Report for 2016

Vigmed Holding AB has today published the Annual Report for 2016. The report is attached to this press release and available on the company website: https://www.vigmed.com/investor

Shareholders and other interested parties who wish to receive a printed copy of the Annual Report 2016 may order it via email to: info@vigmed.com.

An english version of the Annual Report 2016 will be published no later than 13 June, 2017.

Compared to the published Year-End Report for 2016, two adjustments have been made in the Annual Report. Raw materials and consumables in the consolidated income statement for 2016 has been adjusted with +2,2 million SEK related to costs that should not be included in the financial year 2016. Furthermore, result from participations in subsidiaries in the parent company income starerment for 2016 has been adjusted with -2,0 million SEK related to additional shareholder contribution to Vigmed AB.

For further information contact:
Chairman of the Board Sten Dahlborg, +46 708-369 419
CEO Henrik Olsen, +46 763-497 364

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG). Remium Nordic AB is the Company’s Certified Advisor.Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor 

Tags: